Business Context and Reporting Period
Company: cbdMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 24, 2023
Reporting Period: Single event date (May 24, 2023)
Context: The registrant is an emerging growth company incorporated in North Carolina. The filing discloses the commencement of non-deal road shows utilizing a new investor presentation.
Key Financial Metrics
This filing is a disclosure of a corporate event and does not contain audited or unaudited financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
No material changes to financial performance or operations are reported in this document. The primary change is the initiation of a non-deal road show strategy effective May 24, 2023.
Guidance, Outlook, and Management Commentary
- Investor Presentation: Management will begin using the "May 2023 Investor Presentation" (Exhibit 99.1) in non-deal road shows.
- Availability: The presentation is available on the company's website under the "Investor" tab.
- Legal Status of Information: The information in this Item 7.01 and Exhibit 99.1 is furnished, not filed, and is not incorporated by reference into other SEC filings.
- Management: The report was signed by T. Ronan Kennedy, Interim Chief Executive Officer and Chief Financial Officer.
Investor Verification Checklist
- Verify the contents of the "May 2023 Investor Presentation" (Exhibit 99.1) for specific financial guidance or strategic updates not detailed in the 8-K text.
- Confirm the company's status as an emerging growth company and any associated reporting exemptions.
- Review the company's website (www.cbdmd.com) to access the furnished investor deck.
- Note that this filing does not constitute a formal update on financial results; refer to the most recent 10-Q or 10-K for financial data.